FDA Human Subject Protections
The FDA regulations 21 CFR 50 regarding human subject protection in clinical investigations closely mirror the Health and Human Services "Common Rule" which you can also access through this portal. All clinical investigations must comply with both HHS and FDA regulations pertaining to human subjects. A review by an IRB (Insitutional Review Board) will help ensure your research plan aligns with current regulations.
There are no files to display.